SeptAlign™ biosorbable implant for correction of mobile cartilaginous nasal septum deviation: A case report
Year: 2025
Type: article
Study design: Case Report
Abstract: Introduction: The standard of care for symptomatic nasal septal deviation in adults, refractory to medical management, is septoplasty. SeptAlign™ is a minimally-invasive, bioabsorbable implant cleared by the United States Food and Drug Administration for mechanical correction of minor nasal septal deviation and a novel alternative to traditional septoplasty. Presentation of case: We present a case report of a 42 year old male with a history of symptomatic nasal septal deviation and nasal airway obstruction who strongly wished to avoid open surgical correction. Discussion: We successfully implanted the SeptAlign device to correct the cartilaginous deviation with severe anterior caudal deflection. We present pre- and post-procedure computed tomography and endoscopy imaging and patient reported outcomes to demonstrate correction of nasal airway obstruction and symptoms. Conclusion: SeptAlign is a less invasive alternative to traditional septoplasty or septorhinoplasty in patients with cartilaginous nasal septal deviation, with the added benefits of avoiding general anesthesia and the convenience of an in-office procedure.
Authors: Harry E. Zylicz, Caroline Taylor, William Robertson, Mary Ellis Beach, William Barham, Henry P. Barham
Institution: Baton Rouge General
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,090
OpenAlex ID: W4415547271